Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette-Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study.
Joongwon ChoiKyung Hwan KimHyung Suk KimHyun Sik YoonJung Hoon KimJin-Wook KimYong Seong LeeSe Young ChoiIn Ho ChangYoung Hwii KoWan SongByung Chang JeongJong-Kil NamPublished in: Investigative and clinical urology (2024)
Intravesical gemcitabine demonstrated efficacy comparable to BCG therapy for the first year in patients with intermediate- and high-risk NMIBC. However, long-term follow-up studies are warranted.